Atrion (ATRI) Rating Increased to Buy at BidaskClub

Share on StockTwits

Atrion (NASDAQ:ATRI) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday.

Separately, ValuEngine upgraded Atrion from a “hold” rating to a “buy” rating in a research note on Monday, February 4th.

NASDAQ:ATRI opened at $826.50 on Thursday. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of 44.10 and a beta of 0.43. Atrion has a 12-month low of $560.65 and a 12-month high of $830.54.

Large investors have recently added to or reduced their stakes in the business. PNC Financial Services Group Inc. bought a new stake in Atrion in the fourth quarter valued at approximately $130,000. Amundi Pioneer Asset Management Inc. bought a new stake in Atrion in the fourth quarter valued at approximately $148,000. Quantamental Technologies LLC bought a new stake in Atrion in the fourth quarter valued at approximately $149,000. Legal & General Group Plc raised its stake in Atrion by 7.8% in the fourth quarter. Legal & General Group Plc now owns 249 shares of the medical instruments supplier’s stock valued at $185,000 after buying an additional 18 shares during the period. Finally, Jane Street Group LLC bought a new position in shares of Atrion during the fourth quarter worth approximately $202,000. Hedge funds and other institutional investors own 61.74% of the company’s stock.

Atrion Company Profile

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Featured Story: What is a stock buyback?

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

BioScrip  Hits New 1-Year Low at $1.68
BioScrip Hits New 1-Year Low at $1.68
Novacoin Price Hits $0.53 on Top Exchanges
Novacoin Price Hits $0.53 on Top Exchanges
Niobio Cash Hits 1-Day Volume of $427.00
Niobio Cash Hits 1-Day Volume of $427.00
BitMart Token  Price Hits $0.0265 on Top Exchanges
BitMart Token Price Hits $0.0265 on Top Exchanges
Contrasting X Financial  and Its Peers
Contrasting X Financial and Its Peers
Zacks: Brokerages Anticipate Aphria Inc  Will Post Quarterly Sales of $81.65 Million
Zacks: Brokerages Anticipate Aphria Inc Will Post Quarterly Sales of $81.65 Million


© 2006-2019 Ticker Report